Wordt geladen...
Silver-Enhanced In Situ Hybridization as an Alternative to Fluorescence In Situ Hybridization for Assaying HER2 Amplification in Clinical Breast Cancer
PURPOSE: Valid determination of HER2 status is a prerequisite to establish an adequate treatment strategy for breast cancer patients, regardless of the disease stage. The goal of this study was to examine the feasibility of the newly developed silver-enhanced in situ hybridization (SISH) technique a...
Bewaard in:
| Hoofdauteurs: | , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Korean Breast Cancer Society
2011
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3268923/ https://ncbi.nlm.nih.gov/pubmed/22323913 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4048/jbc.2011.14.4.276 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|